IP Library Granted Patent US 10,967,056
Granted Patent B2
US 10,967,056 · App. 16/484,332 · Granted Apr 6, 2021

Proteins and immunizing compositions containing pasteurella proteins and methods of use

Inventors: Charles Nelson Carver, III (Willmar, MN); Daryll Emery (Willmar, MN)
Assignee: Epitopix, LLC
A61K39/102A61K39/39C07K14/285C07K16/1242G01N33/56911A61K2039/552A61K2039/55566G01N2333/285
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,967,056
App. No.
16/484,332
Granted
Apr 6, 2021
Kind
B2
Abstract

The present invention provides isolated proteins isolatable from a Pasteurella spp. such as P. multocida . Also provided by the present invention are compositions that include one or more of the proteins, and methods for making and methods for using the proteins.

Claims (11)

1. A composition comprising: an isolated protein having at least 95% similarity to amino acids 25-968 of SEQ ID NO:2, an isolated protein having at least 95% similarity to amino acids 27-790 of SEQ ID NO:4, an isolated protein having at least 80% similarity to amino acids 23-727 of SEQ ID NO:6, an isolated protein having at least 95% similarity to amino acids 25-964 of SEQ ID NO:8, an isolated protein having at least 95% similarity to amino acids 26-848 of SEQ ID NO: 10, an isolated protein having at least 95% similarity to amino acids 27-784 of SEQ ID NO: 12, and an isolated protein having at least 95% similarity to amino acids 25-742 of SEQ ID NO: 14, and an adjuvant.

2. The composition of claim 1 further comprising: at least one isolated protein having a molecular weight of 249 kDa, 60 kDa, 42 kDa, 38 kDa, 27 kDa, 26 kDa, or 22 kDa, wherein the proteins are isolated from a P. multocida.

3. The composition of claim 1 further comprising a pharmaceutically acceptable carrier.

4. The composition of claim 1 further comprising an isolated protein having at least 80% similarity to amino acids 26-805 of SEQ ID NO:44.

5. A method comprising: administering to a subject an amount of the composition of claim 1 effective to induce the subject to produce antibody that specifically binds to at least one protein of the composition.

6. The method of claim 5 wherein the subject is a mammal.

7. The method of claim 6 wherein the mammal is a bovine.

8. The method of claim 5 wherein the subject is an avian.

9. The method of claim 8 wherein the avian is a chicken or a turkey.

10. The method of claim 5 wherein at least 100 micrograms (μg) and no greater than 2,800 μg of protein is administered.

11. A kit for detecting antibody that specifically binds a protein, comprising in one container the isolated proteins of the composition of claim 1 ; and in a separate second container a reagent that detects an antibody that specifically binds to one of the proteins.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2024
From: EPITOPIX, LLC
To: VAXXINOVA US, INC.
Reel/Frame 066488/0734 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2020
From: CARVER, CHARLES NELSON, III; EMERY, DARYLL A.
To: EPITOPIX, LLC
Reel/Frame 054735/0744 →
Continuity (2)
Provisional Application 62457599 · Feb 10, 2017
Related Publication 20200215177A1 · Jul 9, 2020